Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2025

Feb 14, 2025

29871_dirs_2025-02-14_9371cf10-daff-45d5-a7cc-8253f19a1af5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2025-02-13

Reporting Person: Winkler Julie (Sr MD Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-13 Common Stock Class A S 11592 $249.17 Disposed 21885 Direct

Footnotes

F1: On February 13, 2025, Ms. Winkler sold an aggregate of 11,592 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $249.11 to $249.34. The Company maintains a record of the transaction and copies will be provided upon request.